Profil
Susan Doleman is currently the Vice President-Clinical Operations at Cyteir Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Epizyme, Inc., a Scientist at The Children's Hospital Corp., and the Vice President-Clinical Development Operations at Replimune Group, Inc. Ms. Doleman received her undergraduate degree from Smith College.
Aktiva positioner av Susan Doleman
| Företag | Position | Start |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2019-08-01 |
Tidigare kända positioner av Susan Doleman
| Företag | Position | Slut |
|---|---|---|
| EPIZYME, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Teknisk/Vetenskaplig/F&U Direktör | - |
| REPLIMUNE GROUP, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Susan Dolemans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 5 |
|---|---|
Smith College
Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Health Services |
Epizyme, Inc.
Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Replimune Group, Inc.
Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
















